Ticagrelor or prasugrel in patients with acute coronary syndromes S Schüpke, FJ Neumann, M Menichelli, K Mayer, I Bernlochner, J Wöhrle, ... New England Journal of Medicine 381 (16), 1524-1534, 2019 | 746 | 2019 |
Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment F Otsuka, RA Byrne, K Yahagi, H Mori, E Ladich, DR Fowler, R Kutys, ... European heart journal 36 (32), 2147-2159, 2015 | 464 | 2015 |
Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an … T Adriaenssens, M Joner, TC Godschalk, N Malik, F Alfonso, E Xhepa, ... Circulation 136 (11), 1007-1021, 2017 | 229 | 2017 |
Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial S Schulz-Schüpke, S Helde, S Gewalt, T Ibrahim, M Linhardt, K Haas, ... Jama 312 (19), 1981-1987, 2014 | 203 | 2014 |
Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an … J Riegger, RA Byrne, M Joner, S Chandraratne, AH Gershlick, ... European heart journal 37 (19), 1538-1549, 2016 | 179 | 2016 |
Neointimal modification with scoring balloon and efficacy of drug-coated balloon therapy in patients with restenosis in drug-eluting coronary stents: a randomized controlled trial S Kufner, M Joner, S Schneider, R Tölg, B Zrenner, J Repp, A Starkmann, ... JACC: Cardiovascular Interventions 10 (13), 1332-1340, 2017 | 123 | 2017 |
10-year outcomes from a randomized trial of polymer-free versus durable polymer drug-eluting coronary stents S Kufner, M Ernst, S Cassese, M Joner, K Mayer, R Colleran, T Koppara, ... Journal of the American College of Cardiology 76 (2), 146-158, 2020 | 62 | 2020 |
Transcatheter aortic valve replacement with balloon-expandable valves: comparison of SAPIEN 3 ultra versus SAPIEN 3 T Rheude, C Pellegrini, J Lutz, HA Alvarez-Covarrubias, AL Lahmann, ... Cardiovascular Interventions 13 (22), 2631-2638, 2020 | 59 | 2020 |
Ticagrelor or prasugrel in patients with non–ST-segment elevation acute coronary syndromes C Valina, FJ Neumann, M Menichelli, K Mayer, J Woehrle, I Bernlochner, ... Journal of the American College of Cardiology 76 (21), 2436-2446, 2020 | 54 | 2020 |
Neoatherosclerosis in patients with coronary stent thrombosis: findings from optical coherence tomography imaging (a report of the PRESTIGE Consortium) M Joner, T Koppara, RA Byrne, MI Castellanos, J Lewerich, J Novotny, ... JACC: Cardiovascular Interventions 11 (14), 1340-1350, 2018 | 52 | 2018 |
Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort (PRESTIGE) Investigators. Optical coherence tomography findings in patients with coronary … T Adriaenssens, M Joner, TC Godschalk, N Malik, F Alfonso, E Xhepa, ... Circulation 136 (11), 1007-1021, 2017 | 43 | 2017 |
Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial: Balloon-based techniques for calcific CAD T Rheude, H Rai, G Richardt, A Allali, M Abdel-Wahab, DS Sulimov, ... EuroIntervention 17 (6), 481, 2021 | 42 | 2021 |
Alkaline phosphatase and prognosis in patients with coronary artery disease G Ndrepepa, E Xhepa, S Braun, S Cassese, M Fusaro, H Schunkert, ... European journal of clinical investigation 47 (5), 378-387, 2017 | 40 | 2017 |
Ticagrelor or Prasugrel in Patients with ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention A Aytekin, G Ndrepepa, FJ Neumann, M Menichelli, K Mayer, J Wöhrle, ... Circulation 142 (24), 2329-2337, 2020 | 39 | 2020 |
Meta-analysis of bioprosthetic valve thrombosis after transcatheter aortic valve implantation T Rheude, C Pellegrini, S Stortecky, M Marwan, E Xhepa, F Ammon, ... The American journal of cardiology 138, 92-99, 2021 | 33 | 2021 |
Three-year efficacy and safety of new-versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR … S Cassese, S Kufner, E Xhepa, RA Byrne, J Kreutzer, T Ibrahim, K Tiroch, ... Clinical research in cardiology 105, 575-584, 2016 | 29 | 2016 |
Subphenotyping of patients with aortic stenosis by unsupervised agglomerative clustering of echocardiographic and hemodynamic data M Lachmann, E Rippen, T Schuster, E Xhepa, M von Scheidt, C Pellegrini, ... Cardiovascular Interventions 14 (19), 2127-2140, 2021 | 28 | 2021 |
Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis E Xhepa, RA Byrne, F Rivero, A Rroku, J Cuesta, G Ndrepepa, S Kufner, ... Clinical Research in Cardiology 108, 1059-1068, 2019 | 26 | 2019 |
Inverse association of alanine aminotransferase within normal range with prognosis in patients with coronary artery disease G Ndrepepa, S Holdenrieder, R Colleran, S Cassese, E Xhepa, M Fusaro, ... Clinica Chimica Acta 496, 55-61, 2019 | 23 | 2019 |
Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis: Restenosis characteristics and clinical outcomes E Xhepa, J Bresha, M Joner, A Hapfelmeier, F Rivero, G Ndrepepa, ... EuroIntervention 17 (5), e388, 2021 | 22 | 2021 |